BSEBoard Meeting10 Aug 2026 · 10 Aug 2026, 03:54 pm
Deep Health AI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Dear Sir/ Madam, Pursuant ....
Deep Health AI India Ltd · 539559
✦ AI SummaryResults
Deep Health AI India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Deep Health AI India Ltd - 539559 - Board Meeting Intimation for Prior Intimation Pursuant To Regulation 29 Of The Securities Exchange And Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 For The Board Meeting To Be Held On Thursday, August 13, 2026
Attachments (1)
📄pdf
Download →
e34f6fce-b516-4dbe-891d-434ab966371a.pdf
View document text
DEEP HEALTH AI INDIA LIMITED
(Formerly known as “Deep Diamond India Limited”) CIN: L24100RJ1994PLC112895
Regd. Office: 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11,
Udaipur, Rajasthan (313001) Tel: 0294-3569097.
E-mail: deephealthaiindia@gmail.com Website: www.deephealthaiindia.com
Date: August 10, 2026
The Manager,
BSE Limited
Address: Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai – 400001.
Scrip Code: 539559
Subject: Prior Intimation pursuant to Regulation 29 of the Securities Exchange and Board of India
(Listing Obligations and Disclosure Requirements), Regulations, 2015 for the Board Meeting to be
held on Thursday, August 13, 2026:
Dear Sir/ Madam,
Pursuant to Regulation 29 and other applicable provisions of the Securities Exchange and Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 it is hereby informed that the
meeting of the Board of Directors of Deep Health AI India Limited will be held on Thursday, August 13,
2026 at the Registered office of the Company situated at 506-509 fifth floor, Apeksha, plot no. 256, Main
Road, Hiran Magri, Sector 11, Udaipur, Rajasthan (313001) inter alia, to consider and approve:
a. To Consider and approve the Un-Audited Standalone and Consolidated Financial Results for the
Quarter ended June 30, 2026.
Further, in view of the ensuing Board meeting, the Trading Window for dealing in shares of the Company
has already been closed for all Directors/ KMPs/Designated Employees/ Connected Person of the
Company from July 01, 2026, and will remain closed up to 48 (Forty-Eight) hours after the declaration of
Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (both
days inclusive) in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and the
Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading
by Insiders.
Request you to kindly take the aforementioned information on your records.
FOR DEEP HEALTH AI INDIA LIMITED
(Formerly known as Deep Diamond India Limited)
Narayan Singh Rathore
Managing Director
DIN: 10900646
Place: Udaipur